Embed Size (px)
Citation preview
www.visiongain.com
Contents
1. Report Overview
1.1 World Infusion Pumps Market Highlights
1.2 World Infusion Pumps Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Introduction to Infusion Pumps
2.1 What is an Infusion Pump?
2.2 Types of Infusion
2.3 Types of Pumps
2.3.1 Gravity Controlled Pumps
2.3.2 Positive Displacment Pumps
2.3.2.1 Drip Rate Pumps
2.3.2.2 Volumetric Pumps
2.3.2.3 Syringe Pumps
2.3.2.4 Multi-Channel Pumps
2.3.2.5 Ambulatory Pumps
2.4 History of Infusion Pumps
1. Report Overview
2. Introduction to Infusion Pumps
www.visiongain.com
Contents
2.5 What Clinical Settings Will Infusion Pumps be Useful?
2.5.1Infusion Pumps for Diabetes
2.5.2 Infusion Pumps for Chemotherapy
2.5.3 Infusion Pumps for Analgesia
2.5.4 Infusion Pumps for Enteral Feeding
2.5.5 Other Uses for Infusion Pumps
2.6 Advantages and Disadvantages of Infusion Pumps
2.7 Regulation of the Infusion Pump Market
2.7.1The US Approval and Regulation System
2.7.2 The EU Approval and Regulation System
2.7.2.1 Expected Changes in the New EU Medical Device Regulations
2.7.2.2 When Will the Changes be Finalised?
2.7.2.3 Post Marketing Surveillance in the EU
2.8 Infusion Pump Market Definition
3. Infusion Pumps: World Market 2014-2024
3.1 World Medical Devices Market 2013-2023
3.2 World Infusion Pumps Market 2013
3.3 World Infusion Pumps Market: Sales Forecast 2014-2024
3.3.1 The Infusion Pups Market: Sales Forecast 2013-2018
3.3.2 The Infusion Pups Market: Sales Forecast 2018-2024
3.4 Insulin Pumps Lead the World Speciality Infusion Pumps Market
3.5 How Will Segmental Market Shares Change to 2024?
3.6 World Infusion Pumps Market: Drivers and Restraints 2014-2024
3. Infusion Pumps: World Market 2014-2024
www.visiongain.com
Contents
3.6.1 Ageing Population and Rising Incidences of Chronic Diseases
3.6.2 Advancement in Infusion Pump Technologies
3.6.3 A Shift Towards Home Care
3.6.4 Safety Risk and Stringent Approval Process
4. Leading National Markets 2014-2024
4.1 Regional Breakdown of World Infusion Pumps Market 2013
4.2 Infusion Pumps National Market Forecast 2014-2024
4.2.1 How Will National Market Shares Change to 2024?
4.3 US Infusion Pumps Market 2013
4.3.1 US Infusion Pumps Market Forecast 2014-2024
4.3.2 US Infusion Pumps Market: Trends and Developments
4.3.2.1 Ageing Population and Increase Prevalence of Diabetes
4.3.2.2 HITECH Act: Increase Medical Technology Innovations
4.3.2.3 FDA Infusion Pumps Recall
4.3.2.4 Effects of the US Medical Device Excise Tax
4.3.2.5 Hospital Readmission Reduction Program: Increase Demand for Homecare
4.4 European Infusion Pumps Market 2013
4.4.1 European Infusion Pumps Market forecast 2014-2024
4.4.1.1 How Will European Market Shares Change to 2024?
4.4.2 Europe Infusion Pumps Market: Trends and Developments
4.4.2.1 New EU Medical Device Regulations: Potential Impact on Manufacturers
4.4.3 Germany Infusion Pumps Market Forecast 2014-2024
4.4.3.1 German Infusion Pumps Market: Trends and Developments
4. Leading National Markets 2014-2024
www.visiongain.com
Contents
4.4.4 French Infusion Pumps Market Forecast 2014-2024
4.4.4.1 French Infusion Pumps Market: Trends and Developments
4.4.5 UK Infusion Pumps Market Forecast 2014-2024
4.4.5.1 UK Infusion Pumps Market: Trends and Developments
4.4.6 Italian Infusion Pumps Market Forecast 2014-2024
4.4.6.1 Italian Infusion Pumps Market: Trends and Developments
4.4.7 Spanish Infusion Pumps Market Forecast 2014-2024
4.4.7.1 Spanish Infusion Pumps Market: Trends and Developments
4.5 Japanese Infusion Pumps Market 2013
4.5.1 Japanese Infusion Pumps Market Forecast 2014-2024
4.5.2 Japanese Infusion Pumps Market: Trends and Developments
4.5.2.1 Improved Approval Process
4.5.2.2 The Cost of Treatment in Japan
4.6 Chinese Infusion Pumps Market 2013
4.6.1 Chinese Infusion Pumps Market Forecast 2014-2024
4.6.2 Chinese Infusion Pumps Market: Trends and Developments
4.6.2.1 China’s 12th Five-Year-Plan (2010-2015)
4.6.2.2 New Policies Favouring Domestically-Made Medical Devices
4.7 Indian Infusion Pumps Market 2013
4.7.1 Indian Infusion Pumps Market Forecast 2014-2024
4.7.2 Indian Infusion Pumps Market: Trends and Developments
4.7.2.1 Improved Standard Regulatory Structure
4.7.2.2 Expansion of Healthcare Provision
4.8 Brazilian Infusion Pumps Market 2013
www.visiongain.com
Contents
4.8.1 Brazilian Infusion Pumps Market Forecast 2014-2024
4.8.2 Brazilian Infusion Pumps Market: Trends and Developments
4.8.2.1 Challenges within the Brazilian Medical Devices Market
4.9 South Korean Infusion Pumps Market 2013
4.9.1 South Korean Infusion Pumps Market Forecast 2014-2024
4.9.2 South Korean Infusion Pumps Market: Trends and Developments
4.9.2.1 Expansion of South Korean Medical Devices Market
4.10 Russian Infusion Pumps Market 2013
4.10.1 Russian Infusion Pumps Market Forecast 2014-2024
4.10.2 Russian Infusion Pumps Market: Trends and Developments
4.10.2.1 Russian Healthcare Development Plan 2013-2020
4.10.2.2 New Russian Medical Devices Regulations 2014
5. Insulin Pumps Submarket 2014-2024
5.1 Introduction to Insulin Pumps
5.1.1 The Dosing of Insulin in Insulin Pumps
5.1.1.1 Bolus Infusion
5.1.1.2 Basal Infusion
5.1.2 The Advantages and Disadvantages of Insulin Pumps
5.1.3 Human Insulin and analogues Primarily Used in Insulin Pumps
5.2 Insulin Infusion Pumps Submarket 2013
5.2.1 Insulin Pumps Submarket Regional Breakdown 2013
5.3 Insulin Pumps Submarket: Sales Forecast 2014-2024
5.3.1 Insulin Pumps Submarket: Sales Forecast 2013-2018
5. Insulin Pumps Submarket 2014-2024
www.visiongain.com
Contents
5.3.2 Insulin Pumps Submarket: Sales Forecast 2018-2024
5.4 Leading Products in Insulin Pumps Submarket 2014
5.4.1 OmniPod (Insulet Corporation)
5.4.2 MiniMed Paradigm (Medtronic)
5.4.3 OneTouch Ping (Animas Corporation)
5.4.4 Accu-Chek Spirit (Disetronic, subsidiary of Roche)
5.4.5 t:Slim (Tandem Diabetes Care)
5.4.6 Asante Snap (Asante Solutions)
5.4.7 DANA Diabecare IISG (SOOIL)
5.4.8 SpringZone (D. Medical Industries)
5.4.9 Cellnovo (Cellnovo)
5.4.10 V-Go (Valeritas)
5.5 Key Insulin Pumps Pipeline Products 2014
5.5.1 Finesse Personal Insulin Patch (Johnson & Johnson)
5.5.2 SOLO MicroPump (Roche)
5.5.3 JewelPump (Debiotech)
5.5.4 Artificial Pancreas (Juvenile Diabetes Research Foundation)
5.5.5 PaQ (CeQur)
5.5.6 t:Sensor & t:Flex (Tandem Diabetes Care)
5.5.7 Animas Vibe (Johnson & Johnson)
5.5.8 Freehand (MedSolve Technologies)
5.5.9 NanoPump (Debiotech)
5.5.10 PassPort (Altea Therapeutics)
5.5.11 NiliPatch (D.Medical Industries)
www.visiongain.com
Contents
5.6 Insulin Pumps Submarket: Drivers and Restraints 2014-2024
5.6.1 New Entrants Fuel Innovative Technologies
5.6.2 Collaborations Advance Innovations to Address Unmet Need in Artificial Pancreas
Systems
5.6.3 Strong R&D Pipeline
5.6.4 Rapid Increase in Prevalence of Diabetes Worldwide
5.6.5 Increasing Acceptance of Insulin Pumps in Developed Economies
5.6.6 Reimbursement of Insulin Pumps Will Give Long-Term Economic Benefits
5.6.7 More Expensive Insulin Infusion Therapy Limit Its Successful Penetration in Emerging
Markets
5.6.8 Security Risks with Insulin Pumps
5.7 Concluding Remarks
6. Enteral Feeding Pumps Submarket 2014-2024
6.1 Introduction to Enteral Feeding Pumps
6.1.1 Clinical Settings That May Require Enteral Feeding
6.1.2 Advantages and Disadvantages of Enteral Feeding
6.1.3 Delivery of Enteral Feeding
6.1.3.1 Tube Placements Used in Enteral Feeding
6.1.4 Enteral Feeding at Home
6.2 Enteral Feeding Pumps Submarket 2013
6.2.1 Enteral Feeding Pumps Submarket Regional Breakdown 2013
6.3 Enteral Feeding Pumps Submarket: Sales Forecast 2014-2024
6.3.1 Enteral Feeding Pumps Submarket: Sales Forecast 2013-2018
6. Enteral Feeding Pumps Submarket 2014-2024
www.visiongain.com
Contents
6.3.2 Enteral Feeding Pumps Submarket: Sales Forecast 2018-2024
6.4 Leading Products in Enteral Feeding Pump Submarket 2014
6.4.1 Compat DualFlo Enteral Feeding Pump (Nestle)
6.4.2 Sentinel Enteral Feeding Pump (ALCOR Scientific)
6.4.3 EnteraLite Infinity Enteral Feeding Pump (Moog)
6.4.4 APPLIX Vision (Fresenius Kabi)
6.4.5 MiniFlo (Fresenius Kabi)
6.4.6 Nutricia FloCare Infinity Pump (Danone Nutricia)
6.4.7 Sapphire (Q Core Medical)
6.4.8 Kangaroo Joey Enteral Feeding Pump (Covidien)
6.4.9 Other Notable Enteral Feeding Pumps
6.5 Enteral Feeding Pumps Submarket: Drivers and Restraints 2014-2024
6.5.1 Development of Cost-Effective, Increased Safety and Technologically Advanced
Products
6.5.2 Growing World Geriatric Population and Prevalence of Chronic Diseases
6.5.3 Increasing Demand for Homecare Solutions and Portability
6.5.4 Exit to Abbott in the US Enteral Feeding market in 2013
6.5.5 Introduction of ISO’s Standards for Small-Bore Connectors
6.5.6 Replacement of Pumps and Sales of Disposable Feeding Sets Will Sustain Market
Revenue
6.5.7 Highly Competitive Market with High Barriers to Entry
6.6 Concluding Remarks
www.visiongain.com
Contents
7. Other Infusion Pumps Submarket 2014-2024
7.1 Other Infusion Pumps Submarket Definition
7.2 Other Infusion Pumps Submarket 2013
7.3 Other Infusion Pumps Submarket: Sales Forecast 2014-2024
7.4 Chemotherapy Pumps
7.4.1 Introduction to Chemotherapy Pumps
7.4.2 Advantages and Disadvantages of Chemotherapy Pumps
7.4.3 Leading Drugs in the Cancer Therapeutics Market 2014
7.4.4 Current State of Chemotherapy Pumps Market 2014
7.4.5 Leading Products in Chemotherapy Pumps Market 2014
7.4.5.1 Infusor Infusion Pump (Baxter)
7.4.5.2 CODMAN 3000 (Johnson & Johnson)
7.4.5.3 Optima MS (Fresenius Kabi)
7.4.5.4 CADD Legacy-1 (Smiths Medical)
7.4.5.5 Other Notable Chemotherapy Pumps
7.4.6 Key Chemotherapy Pumps Pipeline Products 2014
7.4.6.1 Metronomic Biofeedback Pump (Pharmaco-Kinesis Corporation)
7.4.7 Chemotherapy Pumps Market: Drivers and Restraints 2014-2024
7.4.8 Concluding Remarks
7.5 Patient Controlled Analgesia Pumps
7.5.1 Introduction to Patient Controlled Analgesia
7.5.1.1 What are PCA Pumps?
7.5.1.2 How Does a PCA Pump Work?
7.5.1.3 Clinical Settings Where PCA Pumps are Used
7. Other Infusion Pumps Submarket 2014-2024
www.visiongain.com
Contents
7.5.1.4 Advantages and Disadvantages of PCA Pumps
7.5.2 Leading Drugs in the Pain Relief Market
7.5.2.1 Narcotic Drugs
7.5.2.2 World Narcotic Pain Relieving Drugs Market: Sales forecast 2014-2024
7.5.3 Current State of PCA Pumps Market 2014
7.5.4 Leading Products in the PCA Pumps Market 2014
7.5.4.1 LifeCare PCA with Hospira MedNet Software (Hospira)
7.5.4.2 GemStar Infusion Pump System (Hospira)
7.5.4.3 Alaris PCA (CareFusion)
7.5.4.4 Baxter PCA II (Baxter)
7.5.4.5 Curlin PainSmart IOD Pain Management System (B.Braun)
7.5.4.6 Perfusor Space PCA Infusion Pump (B.Braun)
7.5.4.7 CADD-Solis Infusion Pump (Smiths Medical)
7.5.4.8 Other Notable PCA Pumps
7.5.5 Key PCA Infusion Pump Pipeline Products 2014
7.5.5.1 MIP (Debiotech)
7.5.6 PCA Pumps Market: Drivers and Restraints 2014-2024
7.5.7 Concluding Remarks
8. Competing Technology Analysis 2014-2024
8.1 Drug Delivery Technologies
8.1.1 Introduction to Drug Delivery Technologies (DDT)
8.1.2 Types of Technologies for Drug Delivery
8.1.2.1 Sustained/Controlled Release Systems
8. Competing Technology Analysis 2014-2024
www.visiongain.com
Contents
8.1.2.2 Injection
8.1.2.3 Needle Free Injections
8.1.2.4 Pulmonary, Buccal and Nasal Delivery
8.1.2.5 Pills and Capsules
8.2 World Drug Delivery Technologies Market 2013
8.2.1 Drug Delivery Technologies Market Regional Breakdown 2013
8.3 World Drug Delivery Technologies Market Forecast 2014-2024
8.4 Key Drug Delivery Pipeline Products 2014
8.5 Concluding Remarks
9. Qualitative Analysis of the Infusion Pumps Market 2014-2024
9.1 SWOT Analysis of World Infusion Pumps Market 2014-2024
9.2 Strengths
9.2.1 Pumpers Have Improved Quality of Life and Less Hospital Visits
9.2.2 Highly Accurate Dosing at Regular Intervals
9.2.3 Usage in a Wide Range of Clinical Settings
9.3 Weaknesses
9.3.1 Expensive Technologies May Restrain the Market
9.3.2 Safety Concerns Will Act to Restrain the Market
9.3.3 Pumps are Cumbersome and May Discourage Potential Users
9.4 Opportunities
9.4.1 Off-Patent Drugs Will Help to Drive the Market
9.4.2 Higher Growth in Emerging Economies
9.4.3 Technological Advancement Opens New Market Opportunities
9. Qualitative Analysis of the Infusion Pumps Market 2014-2024
www.visiongain.com
Contents
9.4.4 Patient Demographics
9.5 Threats
9.5.1 Novel Drug Delivery Systems May be Cheaper and More Effective
9.5.2 Regulatory Authorities are Reluctant to Take Risks
9.5.3 Cost Effectiveness May be Difficult to Prove
9.5.4 Poor Macroeconomic Conditions in Key Regions of the Market
9.5.5 Increasing Bargaining Power of Buyers
9.6 Porter’s Five Force Analysis of the Infusion Pumps Market
9.6.1 Rivalry Among Competitors [High]
9.6.2 Threat of New Entrants [Medium]
9.6.3 Power of Suppliers [Medium]
9.6.4 Bargaining Power of Buyers [High]
9.6.5 Threat of Substitutes [Medium]
10. Research Interviews
10.1 Interview with Prof. Charles Clark, Former Associate Dean at Indiana University School of
Medicine
10.1.1 New Glucose-Analysing Programme
10.1.2 Restraints in the Chinese Insulin Pumps Market
10.1.3 Market Potentials in the Insulin Pumps Market
10.1.4 Opportunities for Infusion Pumps Manufacturers
10.1.5 Size of the Current Chinese Insulin Pumps Market
10.1.6 Challenges Facing Infusion Pumps Manufacturers in Emerging Economies
10.1.7 The Future of Insulin Pumps Market?
10. Research Interviews
www.visiongain.com
Contents
11. Conclusions
11.1 Infusion Pumps: A Growing Specialist Market
11.2 The World Infusion Pumps Market 2014
11.2.1 Leading Infusion Pumps Submarkets 2014
11.2.2 Leading Infusion Pump Products 2014
11.2.3 Leading National Markets 2014
11.3 Infusion Pumps Pipeline Products 2014
11.4 World Infusion Pump Market: Consistent Growth Over 2014-2024
11.5 The Future of the Infusion Pumps Market?
11.5.1 Safety Concerns &Stringent Regulations Will Continue to Restrain the Market
11.5.2 Trend Towards Pumps Usage in Homecare Settings
11.5.3 What Will Succeed in the Infusion Pumps Market?
11. Conclusions
www.visiongain.com Page 75
Infusion Pumps Market Forecast 2014-2024: Prospects for Leading Companies
4.3.2 US Infusion Pumps Market: Trends and Developments
4.3.2.1 Ageing Population and Increase Prevalence of Diabetes
The expanding aging population in the US will keep driving the overall market forward during the
next decade, visiongain predicts. Figure 4.9 shows the current and expected number of people
aged 65 or over in the US throughout the forecast period. The ageing population is resulting in a
rise of age-related conditions, significantly increasing demands on healthcare innovation.
Insulin pumps will continue to see strong revenue in the US. It is currently estimated that diabetes
affects over 24 million residents in the US and is currently the 5th leading cause of death in the
country. According to WHO by the year 2020, approximately 52% of the US population will have
diabetes or pre-diabetes. From a financial viewpoint, diabetes is one of the biggest burdens facing
the government, costing the healthcare system over $130bn per year.
Figure 4.9 shows the United Nations’ (UN) forecast for the number of people aged 65 and over in
the US over the period 2013 - 2024
Figure 4.9 US 65+ Population Forecast: Size (m), 2013-2024
45 46 48 49 51 52 54 56 58 60 61 63
0
10
20
30
40
50
60
70
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Popu
latio
n O
ver 6
5 (m
)
Year
Source: visiongain, 2014; United Nations Department of Economic and Social Affairs, Population Division, 2012.
www.visiongain.com Page 90
Infusion Pumps Market Forecast 2014-2024: Prospects for Leading Companies
reach approximately 17 million by 2050. Consequently, there has been an increase in demand for
infusion pumps in recent years, particularly enteral feeding and insulin pumps.
Table 4.12 and Figure 4.19 show visiongain’s forecast for the UK infusion pumps market over
2013-2024.
Table 4.12 UK Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2013-2024
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
UK ($bn) 0.42 0.44 0.46 0.48 0.50 0.52 0.54 0.57 0.60 0.63 0.67 0.70Annual Growth Rate (%) 4.9 4.5 3.7 3.8 4.0 4.5 5.1 5.3 5.8 5.6 5.5CAGR (%, 2013-2018 and 2018-2024)
4.2 5.3
CAGR (%, 2013-2024) 4.8
Figure 4.19 UK Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), 2013-2024
Growth in the UK market will be, however, limited by severe budgetary constraints that the NHS
will face in the coming years. Additionally, it is reported that the NHS is expected to contribute an
estimated $3.7bn cost savings, which will therefore affect healthcare expenditure in the NHS and
will ultimately affect growth in the infusion pumps market. Moreover, stricter approval guidelines
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0.80
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
AGR
(%)
Sale
s ($b
n)
Year Sales ($bn) AGR (%)
Source: visiongain 2014
Source: visiongain 2014
www.visiongain.com Page 100
Infusion Pumps Market Forecast 2014-2024: Prospects for Leading Companies
leading companies have reported to be increasing their investments in this region of the market.
These factors are expected to continue to sustain the high growth rate in the Chinese infusion
pumps market.
4.6.2 Chinese Infusion Pumps Market: Trends and Developments
4.6.2.1 China’s 12th Five-Year-Plan (2010-2015)
In January 2010, China’s Ministry of Science and Technology was reported to have released the
“12th Five-Year-Plan for the medical device industry”, which emphasised China’s commitments in
developing its domestic medical device industry in order to reduce the country’s reliance on
expensive medical devices. It is expected that this plan will result in an expenditure of $561bn.
Since the reform began in 2010, the Chinese government has invested over $73.9bn, focusing
primarily on expanding coverage of basic medical insurance system and by bridging the gap in
access to healthcare services between urban and rural regions. It is reported that by the end of
2010, there were 340million urban and township residents, as well as 830million rural residents
covered by the basic health insurance system, representing 90% of the total population. Figure
4.24 shows China’s historical healthcare expenditure. In the period 2001-2010, China’s healthcare
expenditure has grown by a CAGR of 29.7%.
Figure 4.24 China’s Historical Healthcare Expenditure ($bn), 2001-2010
6.6 8.0 10.0 11.3 13.8 18.2
27.0
41.6
50.2
68.4
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Hea
lthca
re E
xpen
ditu
re ($
bn)
Year
Source: China’s Ministry of Health 2010; visiongain 2014
www.visiongain.com Page 151
Infusion Pumps Market Forecast 2014-2024: Prospects for Leading Companies
6.5 Enteral Feeding Pumps Submarket: Drivers and Restraints 2014-
2024
Figure 6.4 lists the drivers and restraints in the enteral feeding pump submarket.
Figure 6.4 Enteral Feeding Pumps Submarket: Drivers and Restraints, 2014-2024
6.5.1 Development of Cost-Effective, Increased Safety and
Technologically Advanced Products
Over the years, there have been a number of changes in the design and technology of these
devices in line with the evolving needs of patients and healthcare providers. The introduction of
Source: visiongain 2014
Restraints
• Highly competitive market with high barriers to entry may deter future entrants (section 6.5.7)
• Cost constraints and strict reimbursement policies in US and Europe as result of poor economic conditions
• Safety and accuracy concerns
• High number of product recalls may affect confidence in the market
• More stringent approval process for new products
• Expensive technology
• Development of cost-effective, portable, improved safety and technologically advanced products will accelerate market penetration (section 6.5.1)
• Growing world geriatric population base and growing prevalence of chronic diseases and cases of premature births. (section 6.5.2)
• Increasing demand for homecare solutions and portability (section 6.5.3)
• Exit of Abbott in the US enteral feeding market in 2013 (section 6.5.4)
• Unmet medical needs and improving healthcare infrastructure in emerging economies
• Increased patient awareness
• Introduction of International Organisation of Standardisation (ISO)’s standards for small-bore connectors (section 6.5.5)
• Replacement of pumps and sales of disposable feeding sets will sustain market revenue (section 6.5.6)
Drivers
